Saturday, June 13, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1029 of 1,261

  1. US 7560229

    Methods of use of the enzymes of mycothiol synthesis

    The Regents of the University of California · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted

  2. US 7560265

    Compositions for regulation of tumor necrosis factor-alpha

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 14, 2009 · Expires Jul 9, 2029

    granted

  3. WO 2009084970

    3-N-PHÉNYL-1,3,4-OXADIAZOLONES 5-O-SUBSTITUÉES POUR UNE UTILISATION MÉDICALE

    BIAL PORTELA & COMPANHIA S A [PT] · Granted Jul 9, 2009 · Expires Jul 4, 2029

    granted

  4. US 7557194

    Antibody materials for an IBD-associated polypeptide

    The Regents of the University of California · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  5. US 7557096

    Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

    ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  6. US 7557081

    Alpha-1-acid glycoprotein for the treatment of diabetes

    Essential Skincare, LLC · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  7. US 7557210

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  8. US 7557138

    5-phenoxyalkoxypsoralens and methods for selective inhibition of the voltage gated Kv1.3 potassium channel

    The Regents of the University of California · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  9. US 7556942

    Tumor suppressor designated Hippo

    The Board of Regents of the University of Texas System · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  10. US 7556927

    Methods for diagnosing, imaging and treating atherosclerotic disease

    The Regents of the University of California · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  11. US 7556804

    Anti-HGF-R antibodies and their use

    UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO” · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  12. US 7556926

    Methods for screening insulin-sensitizing agents

    Takeda Pharmaceutical Company Limited · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  13. US 7557084

    IL-18 specific polypeptides and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  14. US 7557126

    Diphenylmethyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  15. US 7557106

    Substituted pyrimidines useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  16. US 7557207

    Spiro 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  17. US 7557196

    hGC-1, a gene encoding a member of the olfactomedin-related protein family

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  18. US 7557247

    Crystalline form of β2 adrenergic receptor agonist

    Theravance, Inc. · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  19. US 7557212

    Tricyclic derivatives as LTD4 antagonists

    Laboratories Almirall, S.A. · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  20. US 7557251

    Production of gossypol co-crystals

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 7, 2009 · Expires Jul 2, 2029

    granted

  21. US 2009169611

    Gel-Formulations of Hydrophobic Photosensitizers for Mucosal Applications

    ALBRECHT VOLKER [DE] · Granted Jul 2, 2009 · Expires Jun 27, 2029

    granted

  22. US 2009171262

    Method and Mixture for In Vivo Photochemical Cross-Linking of Collagen

    GRAEFE SUSANNA [DE] · Granted Jul 2, 2009 · Expires Jun 27, 2029

    granted

  23. AU 2008340179

    Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists

    AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Jul 2, 2009 · Expires Jun 27, 2029

    granted

  24. US 7553840

    4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Jun 30, 2009 · Expires Jun 25, 2029

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.